Immobilization of biological material with an acrylonitrile polymer

• US 4,371,612 A
• Filed: 12/01/1980
• Issued: 02/01/1983
• Est. Priority Date: 02/17/1978
• Status: Expired due to Term

• Current Assignee: Asahi Kasei Kogyo Kabushiki Kaisha
• Original Assignee: Toyo Jozo Co., Ltd.
• Inventors: Matsumoto, Kunio, Mizuguchi, Hiroyuki, Izumi, Rokuro, Seijo, Hideji
• Primary Examiner(s): Naff, David M.
• Application Number:
  US06/211,807
• Time in Patent Office: 792 Days
• Field of Search: 435/174, 435/177, 435/180, 435/181, 435/288, 435/44, 435/47, 435/49
• US Class Current: 435/44
• CPC Class Codes: C08F 8/30 Introducing nitrogen atoms or nitrogen-containing groups
• CPC Class Codes: C12N 11/082 obtained by reactions only involving carbon-to-carbon unsaturated bonds
• CPC Class Codes: C12N 11/087 Acrylic polymers
• CPC Class Codes: C12N 9/0006 acting on CH-OH groups as donors (1.1)
• CPC Class Codes: C12N 9/16 acting on ester bonds (3.1)
• CPC Class Codes: C12N 9/84 Penicillin amidase (3.5.1.11)
• CPC Class Codes: C12P 35/02 by desacylation of the substituent in the 7 position
• CPC Class Codes: C12P 37/06 by desacylation of the substituent in the 6 position

Abstract

Biological material such as enzymes is immobilized by adsorption or covalent bonding to a micro-porous water-insoluble acrylonitrile polymer containing from 20 μM to 1000 μM of amino groups per gram of the polymer. Covalent bonding may be carried out with a crosslinking or condensing agent. The amino groups may be introduced into the polymer by reduction of nitrile groups with lithium aluminum hydride in an inert non-solvent.

Claims

1. An immobilized material comprising a biologically active enzyme bound by covalent bonding with a crosslinking agent or condensing agent onto a carrier which is a water-insoluble acrylonitrile polymer containing from 20 μ

M to 1000 μ

M of amino groups per gram of the polymer and having a porous structure containing a number of micro-pores with an average size of from 40 to 9000 A, said acrylonitrile polymer being produced by effecting reduction of an acrylonitrile polymer having said porous structure in an inert non-solvent with lithium aluminum hydride.

2. An immobilized material according to claim 1, wherein the acrylonitrile polymer containing amino groups is shaped in the form of a fiber, a particle, a membrane or a hollow filament.

3. An immobilized material according to claim 2, wherein the acrylonitrile polymer contains amino groups in an amount which does not make the polymer substantially soluble in water.

4. An immobilized material according to claim 1, wherein the acrylonitrile polymer is a polymer of an acrylonitrile monomer or a copolymer of said monomer with a comonomer containing ethylenically unsaturated double bond.

5. An immobilized material according to claim 4, wherein the acrylonitrile monomer is acrylonitrile, methacrylonitrile, α

-chloroacrylonitrile or cinnamnitrile.

6. An immobilized material according to claim 4, wherein the comonomer is a styrene monomer, an acrylic acid ester monomer, a conjugated diene, a halogenated olefin, a vinyl ether monomer, a vinyl ketone monomer, a vinyl ester monomer, an amide vinyl monomer, a basic monomer or a polyfunctional monomer.

7. An immobilized material according to claim 4, wherein the acrylonitrile polymer comprises polyacrylonitrile containing 90% or more of acrylonitrile shaped in the form of a fiber, a particle, a membrane or a hollow filament.

8. An immobilized material according to claim 4, wherein the acrylonitrile polymer is a copolymer consisting of acrylonitrile, divinyl benzene and vinyl ethyl benzene shaped in the form of a fiber, a particle, a membrane or a hollow filament.

9. An immobilized material according to claim 1, wherein said covalent bonding is effected directly through said crosslinking agent or condensing agent or through said crosslinking agent or condensing agent and through an intermediary spacer.

10. An immobilized material according to claim 9, wherein said crosslinking agent is glutaraldehyde.

11. An immobilized material according to claim 9, wherein said crosslinking agent is glutaraldehyde, crotonaldehyde, acrolein, hexamethylenediamine diisocyanate, hexamethylene-iso-thiocyanate, toluene diisocyanate, xylene diisocyanate, dimethyl adipiimidate, dimethyl suberiimidate, dimethyl-3,3'"'"'-dithio-bis-propionimidate or succinic acid anhydride.

12. An immobilized material according to claim 9, wherein said condensing agent is 1-ethyl-3-(3-dimethylamino-propyl)-carbodiimide.

13. An immobilized material according to claim 9, wherein said spacer is an alkylene diamine.

14. A process for preparing an immobilized material which comprises binding a carrier of a water-insoluble acrylonitrile polymer containing from 20 μ

M to 1000 μ

M of amino groups per gram of the polymer with a biologically active enzyme by covalent bonding with a crosslinking agent or condensing agent in an inert medium;

said polymer having a porous structure containing a number of micro-pores with an average size of 40 to 9000 A, said acrylonitrile polymer being produced by effecting reduction of an acrylonitrile polymer having said porous structure in an inert non-solvent with lithium aluminum hydride.

15. A process according to claim 14, wherein the acrylonitrile polymer containing amino groups is shaped in the form of a fiber, a particle, a membrane or a hollow filament.

16. A process according to claim 14 or claim 15, wherein the acrylonitrile polymer contains amino groups in an amount which does not make the polymer substantially soluble in water.

17. A process according to claim 14, wherein the acrylonitrile polymer is a polymer of an acrylonitrile monomer or a copolymer of said monomer with a comonomer containing ethylenically unsaturated double bond.

18. A process according to claim 17, wherein the acrylonitrile monomer is acrylonitrile, methacrylonitrile, α

-chloroacrylonitrile or cinnamnitrile.

19. A process according to claim 17, wherein the comoner is a styrene monomer, an acrylic acid ester monomer, a conjugated diene, a halogenated olefin, a vinyl ether monomer, a vinyl ketone monomer, a vinyl ester monomer, an amide vinyl monomer, a basic monomer or a polyfunctional monomer.

20. A process according to claim 17, wherein the acrylonitrile polymer comprises polyacrylonitrile containing 90% or more of acrylonitrile shaped in the form of a fiber, a particle, a membrane or a hollow filament.

21. A process according to claim 17, wherein the acrylonitrile polymer is a copolymer consisting of acrylonitrile, divinyl benzene and vinyl ethyl benzene shaped in the form of a fiber, a particle, a membrane or a hollow filament.

22. A process according to claim 14, wherein covalent bonding is effected directly through said crosslinking agent or condensing agent or through said crosslinking agent or condensing agent and through an intermediary spacer.

23. A process according to claim 22, wherein the crosslinking agent is glutaraldehyde, crotonaldehyde, acrolein, hexamethylenediamine diisocyanate, hexamethylene-iso-thiocyanate, toluene diisocyanate, xylene diisocyanate, dimethyl adipiimidate, dimethyl suberiimidate, dimethyl-3,3'"'"'-dithio-bis-propionimidate or succinic acid anhydride.

24. A process according to claim 22, wherein the condensing agent is 1-ethyl-3-(4-dimethylaminopropyl)-carbodiimide.

25. A process according to claim 22, wherein the spacer is an alkylene diamine.

26. A device for promoting an enzymatic reaction comprising a means containing an immobilized material having a biologically active enzyme bound by covalent bonding with a crosslinking agent or condensing agent to a carrier comprising a water-insoluble acrylonitrile polymer containing amino groups and having a porous structure having a number of micro-pores with an average pore size of 40-9000 A, said polymer containing 20 μ

M to 1000 μ

M of amino groups per gram of the polymer and said acrylonitrile polymer being produced by effecting reduction of an acrylonitrile polymer having said porous structure in an inert nonsolvent with lithium aluminum hydride, a storage means containing a liquid substrate on which said biologically active enzyme has an activity and means for transporting at least a portion of the substrate from said storage means to said immobilized material.

27. A device according to claim 26, wherein the acrylonitrile type polymer is shaped in the form of a fiber, a particle, a membrane or a hollow filament.

28. A device according to claim 27, wherein the acrylonitrile type polymer contains amino groups in an amount which does not make the polymer substantially soluble in water.

29. A device according to claim 26, wherein the acrylonitrile polymer is a polymer of an acrylonitrile monomer or a copolymer of said monomer with a comonomer containing ethylenically unsaturated double bond.

30. A device according to claim 29, wherein the acrylonitrile monomer is acrylonitrile, methacrylonitrile, α

-chloroacrylonitrile or cinnamnitrile.

31. A device according to claim 29, wherein the comonomer is a styrene monomer, an acrylic acid ester monomer, a conjugated diene, a halogenated olefin, a vinyl ether monomer, a vinyl ketone type monomer, a vinyl ester monomer, an amide vinyl monomer, a basic monomer or a polyfunctional monomer.

32. A device according to claim 29, wherein the acrylonitrile polymer comprises polyacrylonitrile containing 90% or more of acrylonitrile shaped in the form of a fiber, a particle, a membrane or a hollow filament.

33. A device according to claim 29, wherein the acrylonitrile polymer is a copolymer consisting of acrylonitrile, divinyl benzene and vinyl ethyl benzene shaped in the form of a fiber, a particle, a membrane or a hollow filament.

34. A device according to claim 26, wherein the enzymatic reaction system is a system for detecting electrical change caused by said enzymatic reaction.

35. A device according to claim 34, wherein the electrical change caused by the enzymatic reaction system is a change caused by the oxidizing ability of the reaction product.

36. A device according to claim 26, wherein said means containing the immobilized material comprises a packed column having an inlet and an outlet through which the liquid substrate can pass and the storage means for the liquid substrate comprises a cooled storage tank equipped with a stirrer for effecting agitation of the liquid substrate contained therein and said means for transporting the liquid substrate comprises a conduit means and operatively associated pump means for withdrawing liquid substrate from the storage means and passing the liquid substrate through the packed column and thereafter returning the treated liquid substrate to the said storage means.

37. A device according to claim 36, wherein the storage tank is equipped with a pH meter for adjusting a change in pH within the liquid substrate contained in said tank.

38. A device according to claim 36, wherein said conduit means further includes a heat exchanger for maintaining the liquid substrate at a temperature which will promote reaction with the enzyme bound to the carrier.

39. A device according to claim 26, wherein said covalent bonding is effected directly through said crosslinking agent or condensing agent or through said crosslinking agent or condensing agent and through an intermediary spacer.

40. A device according to claim 39, wherein said crosslinking agent is glutaraldehyde.

41. A device according to claim 39, wherein the crosslinking agent is glutaraldehyde, crotonaldehyde, acrolein, hexamethylenediamine diisocyanate, hexamethylene-iso-thiocyanate, toluene diisocyanate, xylene diisocyanate, dimethyl adipiimidate, dimethyl suberiimidate, dimethyl-3,3'"'"'-dithio-bix-propionimidate or succinic acid anhydride.

42. A device according to claim 39, wherein said condensing agent is 1-ethyl-3-(3-dimethylamino-propyl)-carbodiimide.

43. A device according to claim 39, wherein said spacer is an alkylene diamine.

44. A method for effecting an enzymatic reaction by use of an immobilized material, which comprises reacting an immobilized material comprising a biologically active enzyme bound to a carrier by covalent bonding, with a crosslinking agent or condensing agent, said carrier comprising an acrylonitrile polymer containing amino groups and having a porous structure having a number of micro-pores with an average pore size of 40-9000 A, said polymer containing 20 μ

M to 1000 μ

M of amino groups per gram of the polymer and acrylonitrile polymer being produced by effecting reduction of an acrylonitrile polymer having said porous structure in an inert non-solvent with lithium aluminum hydride, with a substrate on which said biologically active enzyme has activity.

45. A method according to claim 44, wherein the acrylonitrile polymer containing amino groups is shaped in the form of a fiber, a particle, a membrane or a hollow filament.

46. A method according to claim 44 or claim 45, wherein the acrylonitrile type polymer contains amino groups in an amount which does not make the polymer substantially soluble in water.

47. A method according to claim 44, wherein the acrylonitrile type polymer is a polymer of an acrylonitrile monomer or a copolymer of said monomer with a comonomer containing ethylenically unsaturated double bond.

48. A method according to claim 47, wherein the acrylonitrile monomer is acrylonitrile, methacrylonitrile, α

-chloroacrylonitrile or cinnamnitrile.

49. A method according to claim 47, wherein the comonomer is a styrene monomer, an acrylic acid ester monomer, a conjugated diene, a halogenated olefin, a vinyl ether monomer, a vinyl ketone monomer, a vinyl ester monomer, an amide vinyl monomer, a basic monomer or a polyfunctional monomer.

50. A method according to claim 47, wherein the acrylonitrile polymer comprises polyacrylonitrile containing 90% or more of acrylonitrile shaped in the form of a fiber, a particle, a membrane or a hollow filament.

51. A method according to claim 47, wherein the acrylonitrile polymer is a copolymer consisting of acrylonitrile, divinyl benzene and vinyl ethyl benzene shaped in the form of a fiber, a particle, a membrane or a hollow filament.

52. A method according to claim 44, wherein the enzyme is an oxidoreductase, hydrolase, transferase, lyase, isomerase or ligase and the substrate is a liquid medium comprising blood, urine, phospolipids, uric acid and glucose or a solution of a cephalosporin or penicillin compound.

53. A method according to claim 44, wherein said covalent bonding is effected directly through said crosslinking agent or condensing agent or through said crosslinking agent or condensing agent and through an intermediary spacer.

54. A method according to claim 53, wherein the crosslinking agent is glutaraldehyde.

55. A method according to claim 53, wherein the crosslinking agent is glutaraldehyde, crotonaldehyde, acrolein, hexamethylenediamine diisocyanate, hexamethylene-iso-thiocyanate, toluene diisocyanate, xylene diisocyanate, dimethyl adipiimidate, dimethyl suberiimidate, dimethyl-3,3'"'"'-dithio-bis-propionimidate or succinic acid anhydride.

56. A method according to claim 53, wherein the condensing agent is 1-ethyl-3-(3-dimethylamino-propyl)-carbodiimide.

57. A method according to claim 44, wherein the spacer is an alkylene diamine.

58. A process for preparation of 6-aminopenicillanic acid which comprises enzymatically deacylating a benzylpenicillin or alkaline salt thereof by using immobilized penicillin acylase bound to a carrier of water-insoluble acrylonitrile polymer containing from 20 μ

M to 1000 μ

M of amino groups per gram of the polymer, with the penicillin acylase bound by covalent bonding with a crosslinking agent or condensing agent in an inert medium, said polymer having a porous structure containing a number of micro-pores with an average size of 40 to 9000 A, said acrylonitrile polymer being produced by effecting reduction of an acrylonitrile polymer having said porous structure in an inert non-solvent with lithium aluminum hydride.

59. A process according to claim 58, wherein the acrylonitrile polymer comprises polyacrylonitrile containing 90% or more of acrylonitrile shaped in the form of a fiber, a particle, a membrane or a hollow filament.

60. A process according to claim 58, wherein said penicillin acylase is an enzyme preparation obtained from cultured filtrate of penicillin acylase producing microorganisms.

61. A process according to claim 60, wherein the penicillin acylase producing microorganism is a strain belonging to genus Bacillus.

62. A process according to claim 61, wherein said strain is Bacillus megaterium B-400 (FERM-P 748).

63. A process according to claim 58, wherein said crosslinking agent is glutaraldehyde.

64. A process according to claim 58, wherein said micro-pores have an average size of 100 to 2000 A.

65. A process for preparation of 7-amino-desacetoxy cephalosporanic acid which comprises enzymatically deacylating a 7-phenylacetamidodesacetoxy cephalosporanic acid by using immobilized acylase bound to a carrier of water-insoluble acrylonitrile polymer containing from 20 μ

M to 1000 μ

M of amino groups per gram of the polymer, with the acylase bound by covalent bonding with a crosslinking agent or condensing agent in an inert medium, said polymer having a porous structure containing a number of micro-pores with an average size of 40 to 9000 A, said acrylonitrile polymer being produced by effecting reduction of an acrylonitrile polymer having said porous structure in an inert non-solvent with lithium aluminum hydride.

66. A process according to claim 65, wherein the acrylonitrile polymer comprises polyacrylonitrile containing 90% or more of acrylonitrile shaped in the form of a fiber, a particle, a membrane or a hollow filament.

67. A process according to claim 65, wherein said acylase is an enzyme preparation obtained from cultured filtrate of acylase producing microorganisms.

68. A process according to claim 67, wherein the acylase producing microorganism is a strain belonging to genus Bacillus.

69. A process according to claim 68, wherein said strain is Bacillus megaterium B-400 (FERM-P 748).

70. A process according to claim 65, wherein said crosslinking agent is glutaraldehyde.

71. A process according to claim 65, wherein said micropores have an average size of 100 to 2000 A.